Advertisement

Rheumatology International

, Volume 38, Issue 9, pp 1601–1613 | Cite as

Living with systemic lupus erythematosus in the developing world

  • A. Phuti
  • M. Schneider
  • M. Tikly
  • B. Hodkinson
Review

Abstract

Most of our understanding of SLE and its negative impact originates from developed countries. This review aims to collate existing literature on Health-Related Quality of Life (HRQoL) in SLE patients living in developing countries to identify the gaps for the focus of future research. A narrative literature review was compiled using selected MeSH terms to search EBSCOHOST for articles published between January 1975 and February 2018 pertaining to HRQoL in SLE patients in developing countries. 31 studies from 11 countries were included for analysis. Only one longitudinal, one randomized controlled trial (RCT), one qualitative study, and two intervention studies were found. High disease activity and organ damage were associated with poor functional ability, mental health and low socio-economic status (SES). Poor SES is a recurring theme in developing countries, and worsens all SLE outcomes by reducing access to healthcare, mental, social and emotional support systems. In developing countries, SLE has a globally negative impact on patients’ HRQoL, similar to that seen in developed countries. There is an urgent need for more HRQoL studies, and in particular, longitudinal, qualitative and interventional studies in these countries to investigate unmet needs, and to explore novel strategies to improve patient outcomes.

Keywords

Systemic lupus erythematosus Health-Related Quality of Life Developing world 

Notes

Acknowledgements

The authors acknowledge financial support from the South African National Research Fund.

Author contributions

AP, MS, MT and BH were involved in the conceptualization, planning and execution of this review. All authors contributed to data synthesis and interpretation, simultaneous draft review and the final version of the manuscript.

Compliance with ethical standards

Conflict of interest

Angel Phuti (AP), Marguerite Schneider (MS) and Mohammed Tikly (MT) received no research grants and each declare no conflict of interest. This study was funded by the National Research Fund (NRF); South Africa—Thuthuka Grant no: 443812. Bridget Hodkinson (BH) received this research grant and declares that she has no conflict of interest.

Informed consent

This narrative review includes research studies that enrolled human subjects who had individually given an informed consent.

Research involving human participants

All procedures performed in the studies (included in this review) involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Supplementary material

296_2018_4017_MOESM1_ESM.docx (14 kb)
Supplementary material 1 (DOCX 14 KB)

References

  1. 1.
    Merrell M, Shulman LE (1955) Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis 1(1):12–32CrossRefPubMedGoogle Scholar
  2. 2.
    Nossent J, Cikes N, Kiss E, Marchesoni A, Nassonova V, Mosca M, Olesinska M, Pokorny G, Rozman B, Schneider M, Vlachoyiannopoulos PG, Swaak A (2007) Current causes of death in systemic lupus erythematosus in Europe, 2000–2004: relation to disease activity and damage accrual. Lupus 16(5):309–317.  https://doi.org/10.1177/0961203307077987 CrossRefPubMedGoogle Scholar
  3. 3.
    Benseler SM, Silverman ED (2007) Systemic lupus erythematosus. Rheum Dis Clin N Am 33(3):471–498, vi.  https://doi.org/10.1016/j.rdc.2007.07.008 CrossRefGoogle Scholar
  4. 4.
    Tsokos GCGC., Smolen JS (2007) Systematic lupus erythematosus—a companion to rheumatology. 1st edn. Mosby Elsevier, USAGoogle Scholar
  5. 5.
    Lateef A, Petri M (2012) Unmet medical needs in systemic lupus erythematosus. Arthritis Res Ther 14(Suppl 4):S4.  https://doi.org/10.1186/ar3919 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    World Health Organisation (1997) WHOQOL: measuring quality of life. http://www.who.int/mental_health/media/68.pdf. Accessed 12 Dec 2016
  7. 7.
    World Health Organisation (2001) International classification of functioning, disability and health (ICF). http://www.who.int/classifications/icf/en/. Accessed 9 Oct 2017
  8. 8.
    Alarcon GS, McGwin G Jr, Uribe A, Friedman AW, Roseman JM, Fessler BJ, Bastian HM, Baethge BA, Vila LM, Reveille JD (2004) Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum 51(3):465–474.  https://doi.org/10.1002/art.20409 CrossRefPubMedGoogle Scholar
  9. 9.
    Benitha R, Tikly M (2007) Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 26(1):24–29.  https://doi.org/10.1007/s10067-006-0215-4 CrossRefPubMedGoogle Scholar
  10. 10.
    da Silva JP, Amadei JL (2016) Influence of medical care in the quality of life (WHOQOL-100) of women living with systemic lupus erythematosus. Rev Bras Reumatol Engl Ed 56(3):198–205.  https://doi.org/10.1016/j.rbre.2015.08.017 CrossRefPubMedGoogle Scholar
  11. 11.
    Curry SL, Levine SB, Corty E, Jones PK, Kurit DM (1994) The impact of systemic lupus erythematosus on women’s sexual functioning. J Rheumatol 21(12):2254–2260PubMedGoogle Scholar
  12. 12.
    Zhu TY, Tam LS, Li EK (2012) Labour and non-labour market productivity in Chinese patients with systemic lupus erythematosus. Rheumatology 51(2):284–292.  https://doi.org/10.1093/rheumatology/ker247 CrossRefPubMedGoogle Scholar
  13. 13.
    Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483CrossRefPubMedGoogle Scholar
  14. 14.
    dos Reis MG, da Costa IP (2010) Health-related quality of life in patients with systemic lupus erythematosus in Midwest Brazil. Rev Bras Reumatol 50(4):408–422CrossRefPubMedGoogle Scholar
  15. 15.
    Abdul-Sattar AB, Abou El Magd S (2014) Association of perceived neighborhood characteristics, socioeconomic status and rural residency with health outcomes in Egyptian patients with systemic lupus erythematosus: one center study. Int J Rheum Dis.  https://doi.org/10.1111/1756-185X.12331 CrossRefPubMedGoogle Scholar
  16. 16.
    García Carrasco M, Mendoza Pinto C, López Colombo A, Méndez Martínez S, Andari Sawaya R, Muñoz Guarneros M, Vázquez De Lara L, Lescas Hernández M, Montiel Jarquín A, Ramos Álvarez G, Schmulson M (2013) Irritable bowel syndrome-type symptoms in female patients with mild systemic lupus erythematosus: frequency, related factors and quality of life. Neurogastroenterol Motil 25(12):958–966.  https://doi.org/10.1111/nmo.12230 CrossRefPubMedGoogle Scholar
  17. 17.
    Chandrasekhara PK, Jayachandran NV, Rajasekhar L, Thomas J, Narsimulu G (2009) The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol 19(4):407–415.  https://doi.org/10.1007/s10165-009-0185-x CrossRefPubMedGoogle Scholar
  18. 18.
    Valencia-Flores M, Resendiz M, Castano VA, Santiago V, Campos RM, Sandino S, Valencia X, Alcocer J, Ramos GG, Bliwise DL (1999) Objective and subjective sleep disturbances in patients with systemic lupus erythematosus. Arthritis and rheumatism 42(10):2189–2193. https://doi.org/10.1002/1529-0131(199910)42:10<2189::AID-ANR21>3.0.CO;2-VCrossRefPubMedGoogle Scholar
  19. 19.
    Zakeri Z, Shakiba M, Narouie B, Mladkova N, Ghasemi-Rad M, Khosravi A (2012) Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience. Rheumatol Int 32(5):1179–1187.  https://doi.org/10.1007/s00296-010-1791-9 CrossRefPubMedGoogle Scholar
  20. 20.
    Schmeding A, Schneider M (2013) Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 27(3):363–375.  https://doi.org/10.1016/j.berh.2013.07.009 CrossRefPubMedGoogle Scholar
  21. 21.
    Danchenko N, Satia JA, Anthony MS (2006) Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15(5):308–318CrossRefPubMedGoogle Scholar
  22. 22.
    Tiffin N, Hodkinson B, Okpechi I (2014) Lupus in Africa: can we dispel the myths and face the challenges? Lupus 23(1):102–111.  https://doi.org/10.1177/0961203313509296 CrossRefPubMedGoogle Scholar
  23. 23.
    Tikly M, Navarra SV (2008) Lupus in the developing world—is it any different? Best Pract Res Clin Rheumatol 22(4):643–655.  https://doi.org/10.1016/j.berh.2008.05.003 CrossRefPubMedGoogle Scholar
  24. 24.
    Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409–1417.  https://doi.org/10.1007/s00296-011-1999-3 CrossRefPubMedGoogle Scholar
  25. 25.
    Green BN, Johnson CD, Adams A (2006) Writing narrative literature reviews for peer-reviewed journals: secrets of the trade. J Chiropr Med 5(3):101–117.  https://doi.org/10.1016/S0899-3467(07)60142-6 CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Gough D, Thomas J, Oliver S (2012) Clarifying differences between review designs and methods. Syst Rev 1:28.  https://doi.org/10.1186/2046-4053-1-28 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https://doi.org/10.1002/1529-0131(199709)40:9<1725::AID-ART29>3.0.CO;2-YCrossRefPubMedGoogle Scholar
  28. 28.
    Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677–2686.  https://doi.org/10.1002/art.34473 CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    United Nations (2016) World economic situation and prospects 2016. https://www.un.org/development/desa/dpad/wpcontent/uploads/sites/45/2016wesp_update.pdf. Accessed Jan 2016
  30. 30.
    Raafat HA, El Refai RM, Alrasheed HA, El Din MN (2015) Major depression and disease activity among systemic lupus erythematosus Egyptian females. Egypt Rheumatol 37(4):S1–S6.  https://doi.org/10.1016/j.ejr.2015.09.007 CrossRefGoogle Scholar
  31. 31.
    Odhiambo J, Oyoo GO, Amayo E (2014) An Evaluation of quality of life of patients with systemic lupus erythematosus attending rheumatology clinic in Kenyatta National Hospital, Nairobi, Kenya. Arthritis Rheumatol 2(1):18–22Google Scholar
  32. 32.
    Kotb HA, Rady HM, Ghanim DH (2013) Sleep disturbance in female patients with systemic lupus erythematosus and its relation to disease parameters. Egypt Rheumatol 35(3):127–132.  https://doi.org/10.1016/j.ejr.2013.02.003 CrossRefGoogle Scholar
  33. 33.
    Rizk A, Gheita TA, Nassef S, Abdallah A (2012) The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis. Int J Rheum Dis 15(3):261–267.  https://doi.org/10.1111/j.1756-185X.2011.01698.x CrossRefPubMedGoogle Scholar
  34. 34.
    Sliem H, Tawfik G, Khalil KA, Ibrahim N (2010) Pattern of systemic lupus erythematosus in Egyptian patients: the impact of disease activity on the quality of life. Pan Afr Med J 6:14PubMedGoogle Scholar
  35. 35.
    Solati K, Mousavi M, Kheiri S, Hasanpour-Dehkordi A (2017) The effectiveness of mindfulness-based cognitive therapy on psychological symptoms and quality of life in systemic lupus erythematosus patients: a randomized controlled trial. Oman Med J 32(5):378–385.  https://doi.org/10.5001/omj.2017.73 CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Mirbagher L, Gholamrezaei A, Hosseini N, Sayed Bonakdar Z (2016) Sleep quality in women with systemic lupus erythematosus: contributing factors and effects on health-related quality of life. Int J Rheum Dis 19(3):305–311.  https://doi.org/10.1111/1756-185X.12418 CrossRefPubMedGoogle Scholar
  37. 37.
    Tseng JC, Lu LY, Hu JC, Wang LF, Yen LJ, Wu HC, Jiann BP (2011) The impact of systemic lupus erythematosus on women’s sexual functioning. J Sex Med 8(12):3389–3397.  https://doi.org/10.1111/j.1743-6109.2011.02464.x CrossRefPubMedGoogle Scholar
  38. 38.
    Muhammed H, Goyal M, Lal V, Singh S, Dhir V (2017) Neuropsychiatric manifestations are not uncommon in Indian lupus patients and negatively affect quality of life. Lupus.  https://doi.org/10.1177/0961203317747720 PubMedCrossRefGoogle Scholar
  39. 39.
    Zheng Y, Ye DQ, Pan HF, Li WX, Li LH, Li J, Li XP, Xu JH (2009) Influence of social support on health-related quality of life in patients with systemic lupus erythematosus. Clin Rheumatol 28(3):265–269.  https://doi.org/10.1007/s10067-008-1033-7 CrossRefPubMedGoogle Scholar
  40. 40.
    Mok CC, Ho LY, Cheung MY, Yu KL, To CH (2009) Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Scand J Rheumatol 38(2):121–127.  https://doi.org/10.1080/03009740802415527 CrossRefPubMedGoogle Scholar
  41. 41.
    Khanna S, Pal H, Pandey RM, Handa R (2004) The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology 43(12):1536–1540.  https://doi.org/10.1093/rheumatology/keh376 CrossRefPubMedGoogle Scholar
  42. 42.
    Huang H, Chou C, Lin K, Chao Y (2007) The relationships between disability level, health-promoting lifestyle, and quality of life in outpatients with systemic lupus erythematosus. J Nurs Res (Taiwan Nurses Assoc) 15(1):21–32CrossRefGoogle Scholar
  43. 43.
    Elera-Fitzcarrald C, Alva M, Gamboa-Cardenas R, Mora-Trujillo CS, Zevallos F, Garcia-Poma A, Medina M, Rodriguez-Bellido Z, Perich-Campos RA, Pastor-Asurza CA, Segami MI, Ugarte-Gil MF (2018) Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus. Lupus.  https://doi.org/10.1177/0961203317751062 PubMedCrossRefGoogle Scholar
  44. 44.
    Etchegaray-Morales I, Méndez-Martínez S, Jiménez-Hernández C, Mendoza-Pinto C, Alonso-García NE, Montiel-Jarquín A, López-Colombo A, García-Villaseñor A, Cardiel MH, García-Carrasco M (2017) Factors associated with health-related quality of life in Mexican Lupus patients using the LupusQol. PLoS One 12(1):1–10.  https://doi.org/10.1371/journal.pone.0170209 CrossRefGoogle Scholar
  45. 45.
    Mendoza-Pinto C, Méndez-Martínez S, Soto-Santillán P, Galindo Herrera J, Pérez-Contreras I, Macías-Díaz S, Taboada-Cole A, García-Carrasco M (2015) Socioeconomic status and organ damage in Mexican systemic lupus erythematosus women. Lupus 24(11):1227–1232.  https://doi.org/10.1177/0961203315591621 CrossRefPubMedGoogle Scholar
  46. 46.
    Saavedra MA, Sánchez A, Morales S, Navarro-Zarza JE, Ángeles U, Jara LJ (2015) Primigravida is associated with flare in women with systemic lupus erythematosus. Lupus 24(2):180–185.  https://doi.org/10.1177/0961203314552116 CrossRefPubMedGoogle Scholar
  47. 47.
    Garcia-Carrasco M, Mendoza-Pinto C, Cardiel MH, Mendez-Martinez S, Garcia-Villasenor A, Jimenez-Hernandez C, Alonso-Garcia NE, Briones-Rojas R, Ramos-Alvarez G, Lopez-Colombo A (2012) Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL(C). Lupus 21(11):1219–1224.  https://doi.org/10.1177/0961203312456749 CrossRefPubMedGoogle Scholar
  48. 48.
    Miles A (2011) Emerging chronic illness: women and lupus in ecuador. Health Care Women Int 32(8):651–668.  https://doi.org/10.1080/07399332.2010.529214 CrossRefPubMedGoogle Scholar
  49. 49.
    Medeiros MM, Menezes AP, Silveira VA, Ferreira FN, Lima GR, Ciconelli RM (2008) Health-related quality of life in patients with systemic lupus erythematosus and its relationship with cyclophosphamide pulse therapy. Eur J Intern Med 19(2):122–128.  https://doi.org/10.1016/j.ejim.2007.06.012 CrossRefPubMedGoogle Scholar
  50. 50.
    Ferraz LB, Almeida FA, Vasconcellos MR, Faccina AS, Ciconelli RM, Ferraz MB (2006) The impact of lupus erythematosus cutaneous on the quality of life: the Brazilian-Portuguese version of DLQI. Qual Life Res 15(3):565–570.  https://doi.org/10.1007/s11136-005-2638-9 CrossRefPubMedGoogle Scholar
  51. 51.
    Ruperto N, Buratti S, Duarte-Salazar C, Pistorio A, Reiff A, Bernstein B, Maldonado-Velazquez MR, Beristain-Manterola R, Maeno N, Takei S, Falcini F, Lepore L, Spencer CH, Pratsidou-Gertsi P, Martini A, Ravelli A (2004) Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage. Arthritis Rheum 51(3):458–464.  https://doi.org/10.1002/art.20412 CrossRefPubMedGoogle Scholar
  52. 52.
    Ravelli A, Duarte-Salazar C, Buratti S, Reiff A, Bernstein B, Maldonado-Velazquez MR, Beristain-Manterola R, Maeno N, Takei S, Gerloni V, Spencer CH, Pratsidou-Gertsi P, Ruperto N, Pistorio A, Martini A (2003) Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 49(4):501–507.  https://doi.org/10.1002/art.11205 CrossRefPubMedGoogle Scholar
  53. 53.
    Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Fossel AH, Roberts WN, Stern SH, Straaton KV, Wacholtz MC, Kavanaugh AF, Grosflam JM, Liang MH (1997) The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 40(1):47–56CrossRefPubMedGoogle Scholar
  54. 54.
    Marais BJ, Lonnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, Bates M, Colagiuri R, Zijenah L, Swaminathan S, Memish ZA, Pletschette M, Hoelscher M, Abubakar I, Hasan R, Zafar A, Pantaleo G, Craig G, Kim P, Maeurer M, Schito M, Zumla A (2013) Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis 13(5):436–448.  https://doi.org/10.1016/S1473-3099(13)70015-X CrossRefPubMedGoogle Scholar
  55. 55.
    Bae SC, Hashimoto H, Karlson EW, Liang MH, Daltroy LH (2001) Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus. J Rheumatol 28(6):1245–1251PubMedGoogle Scholar
  56. 56.
    Devins GM, Edworthy SM (2000) Illness intrusiveness explains race-related quality-of-life differences among women with systemic lupus erythematosus. Lupus 9(7):534–541.  https://doi.org/10.1177/096120330000900710 CrossRefPubMedGoogle Scholar
  57. 57.
    Fischer-Betz R, Wessel E, Richter J, Winkler-Rohlfing B, Willers R, Schneider M (2005) Lupus in Germany: analysis within the German lupus self-help organization (LULA). Z Rheumatol 64(2):111–122.  https://doi.org/10.1007/s00393-005-0644-5 CrossRefPubMedGoogle Scholar
  58. 58.
    Klein R, Moghadam-Kia S, Taylor L, Coley C, Okawa J, LoMonico J, Chren MM, Werth VP (2011) Quality of life in cutaneous lupus erythematosus. J Am Acad Dermatol 64(5):849–858.  https://doi.org/10.1016/j.jaad.2010.02.008 CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Kulczycka L, Sysa-Jedrzejowska A, Robak E (2010) The influence of treatment on quality of life in systemic lupus erythematosus patients. J Eur Acad Dermatol Venereol 24(1):38–42.  https://doi.org/10.1111/j.1468-3083.2009.03348.x CrossRefPubMedGoogle Scholar
  60. 60.
    Pettersson S, Moller S, Svenungsson E, Gunnarsson I, Welin Henriksson E (2010) Women’s experience of SLE-related fatigue: a focus group interview study. Rheumatology 49(10):1935–1942.  https://doi.org/10.1093/rheumatology/keq174 CrossRefPubMedGoogle Scholar
  61. 61.
    Sterling K, Gallop K, Swinburn P, Flood E, French A, Al Sawah S, Iikuni N, Naegeli A, Nixon A (2014) Patient-reported fatigue and its impact on patients with systemic lupus erythematosus. Lupus 23(2):124–132.  https://doi.org/10.1177/0961203313511554 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Rheumatology Division, Department of MedicineJ47 Old Groote Schuur Hospital, University of Cape TownCape TownSouth Africa
  2. 2.Alan J Flisher Centre for Public Mental HealthUniversity of Cape TownCape TownSouth Africa
  3. 3.Division of Rheumatology, Department of MedicineChris Hani Baragwanath Academic Hospital, University of WitwatersrandJohannesburgSouth Africa

Personalised recommendations